Holiday notice: from 1pm Monday 21 September, all orders will be dispatched on Tuesday 29 September. Order as normal — everything ships the day we're back. Thank you!

All peptides
NewMazdutide 10mg research peptide vial — buy Mazdutide 10mg UK | Peptides UK 4U
Weight & Metabolic

Mazdutide 10mg

Dual GLP-1 / glucagon receptor agonist (LY3305677), lyophilised powder (10mg, 99%+ purity) for in vitro research into metabolic and appetite-signalling pathways.

How would you like it prepared?
Recommended
Vial
Best value · Same-day dispatch
Lowest cost per mg — you reconstitute it yourself
£62.00
Pre-filled Quick Pen (V2)
Made to order · +£34.99
Ready-made pen, needles & dosing guide
£96.99
£34.99 more than the vial
Pre-filled Replacement Cartridge
Made to order · +£12.99
Refill only — you must already own a Quick Pen
£74.99
£12.99 more than the vial

Best value and fastest option — supplied as a lyophilised vial, dispatched same day on orders before 1pm. Use our calculator for your target concentration.

£62.00
£6.20/mg · cost per milligram
SKU: MAZ10

For In Vitro Use Only — Not for Human Use

Lab-Verified Purity
View COAs
99%+
HPLC purity
Mass-Spec
Identity verified
Batch CoA
Independent lab

Every batch is independently HPLC & mass-spec tested. Certificate of Analysis is batch-numbered and matched to the vial you receive.

Verified customer WhatsApp support group
Invite-only. Your personal invite link is sent automatically with your shipping confirmation after your first order — please don't message us to request it. Reconstitution help, batch COAs and protocol guidance.
99%+ HPLC purity
Same-day UK dispatch
UK-registered Ltd
WhatsApp support

Overview

Mazdutide 10mg is a synthetic dual GLP-1 and glucagon (GCG) receptor agonist peptide, supplied as a lyophilised powder for laboratory research use. Also referenced as LY3305677 and IBI362, it is studied in controlled environments for its dual-pathway receptor activity within metabolic research models.

Research

Within laboratory settings, Mazdutide is investigated for its simultaneous engagement of GLP-1 and glucagon receptors — a mechanism distinct from single-agonist analogues such as semaglutide and from the GLP-1/GIP profile of tirzepatide. Research interest commonly focuses on energy-expenditure signalling, appetite-pathway modelling, and comparative receptor-affinity studies under controlled experimental conditions.

View basket0Checkout